跳到主内容Skip to content
Debunking Matrix
The claimEvidence against it: low (plausible mechanism, few human trials)

Lutein prevents nearsightedness

The evidence

Lutein collects in the macula, and its trial evidence is for intermediate macular degeneration; nearsightedness is the eyeball growing too long, which no supplement can change. Healthy people just need enough greens and eggs.

Why the claim spreads

Lutein really does collect in the eye, and the eye formula really is backed by a large trial; once the words eye protection appear, they are easily moved over to children's nearsightedness.

The mechanism, in brief

The eye supplement has trial evidence only in people with intermediate macular degeneration or late disease in one eye, so whether to take it comes down to whether your macula already shows intermediate disease. Only an eye doctor who has looked at the back of your eye can tell you.

Sources (4)
  • Age-Related Eye Disease Study 2 Research Group. (2013). Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA, 309(19), 2005-2015.
  • Hammond, B. R., Miller, L. S., Bello, M. O., Lindbergh, C. A., Mewborn, C., Renzi-Hammond, L. M. (2017). Effects of Lutein/Zeaxanthin Supplementation on the Cognitive Function of Community Dwelling Older Adults: A Randomized, Double-Masked, Placebo-Controlled Trial. Frontiers in Aging Neuroscience, 9.
  • Bone, R. A., Landrum, J. T., Cao, Y., Howard, A. N., Alvarez-Calderon, F. (2007). Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin. Nutrition & Metabolism, 4(1), 12.
  • Singh, S., Keller, P. R., Busija, L., McMillan, P., Makrai, E., Lawrenson, J. G., Hull, C. C., & Downie, L. E. (2023). Blue-light filtering spectacle lenses for visual performance, sleep, and macular health in adults. Cochrane Database of Systematic Reviews, (8), CD013244.
Read the full mechanismOpens the atlas story at the scene that explains this claim.

Related debunks